Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:3453565rdf:typepubmed:Citationlld:pubmed
pubmed-article:3453565lifeskim:mentionsumls-concept:C0237868lld:lifeskim
pubmed-article:3453565lifeskim:mentionsumls-concept:C0002006lld:lifeskim
pubmed-article:3453565lifeskim:mentionsumls-concept:C0036679lld:lifeskim
pubmed-article:3453565lifeskim:mentionsumls-concept:C0220781lld:lifeskim
pubmed-article:3453565lifeskim:mentionsumls-concept:C0870883lld:lifeskim
pubmed-article:3453565lifeskim:mentionsumls-concept:C0392756lld:lifeskim
pubmed-article:3453565lifeskim:mentionsumls-concept:C1883254lld:lifeskim
pubmed-article:3453565lifeskim:mentionsumls-concept:C0008562lld:lifeskim
pubmed-article:3453565pubmed:issue6lld:pubmed
pubmed-article:3453565pubmed:dateCreated1988-8-18lld:pubmed
pubmed-article:3453565pubmed:abstractTextSpecific methods are described for the enzymatic synthesis of each of the six possible 3H-labeled Ring-A reduced metabolites of aldosterone (5 alpha- and 5 beta-DHAldo; 3 alpha,5 alpha-THAldo; 3 beta,5 alpha-THAldo; 3 alpha,5 beta-THAldo; and 3 beta,5 beta-THAldo; see footnote 1 for full names). Use of heated jacketed columns (C8-reverse phase) and two HPLC solvent systems, with isocratic aqueous methanol or acetonitrile, respectively, have been developed which resolve all six Ring-A reduced metabolites of aldosterone. The relative retention times and elution order of each reduced metabolite are different with each solvent system and hence help confirm the identities of Ring-A reduced metabolites made in vivo from physiological quantities of [3H]aldosterone. The use of an on-line beta-radioactivity detector (Berthold LB-504) enhanced the sensitivity of detection and markedly improved the resolution of these metabolites, compared with that obtained by off-line scintillation counting. Thus, the use of increased temperature with these two solvent systems, together with an on-line radioactivity detector, provide a useful and efficient analytical tool for the separation and identification of each reduced metabolite of aldosterone.lld:pubmed
pubmed-article:3453565pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3453565pubmed:languageenglld:pubmed
pubmed-article:3453565pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3453565pubmed:citationSubsetIMlld:pubmed
pubmed-article:3453565pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3453565pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3453565pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3453565pubmed:statusMEDLINElld:pubmed
pubmed-article:3453565pubmed:monthJunlld:pubmed
pubmed-article:3453565pubmed:issn0039-128Xlld:pubmed
pubmed-article:3453565pubmed:authorpubmed-author:MorrisD JDJlld:pubmed
pubmed-article:3453565pubmed:authorpubmed-author:LatifS ASAlld:pubmed
pubmed-article:3453565pubmed:authorpubmed-author:CamaraPPlld:pubmed
pubmed-article:3453565pubmed:authorpubmed-author:RosenM PMPlld:pubmed
pubmed-article:3453565pubmed:issnTypePrintlld:pubmed
pubmed-article:3453565pubmed:volume49lld:pubmed
pubmed-article:3453565pubmed:ownerNLMlld:pubmed
pubmed-article:3453565pubmed:authorsCompleteYlld:pubmed
pubmed-article:3453565pubmed:pagination589-600lld:pubmed
pubmed-article:3453565pubmed:dateRevised2007-11-14lld:pubmed
pubmed-article:3453565pubmed:meshHeadingpubmed-meshheading:3453565-...lld:pubmed
pubmed-article:3453565pubmed:meshHeadingpubmed-meshheading:3453565-...lld:pubmed
pubmed-article:3453565pubmed:meshHeadingpubmed-meshheading:3453565-...lld:pubmed
pubmed-article:3453565pubmed:meshHeadingpubmed-meshheading:3453565-...lld:pubmed
pubmed-article:3453565pubmed:meshHeadingpubmed-meshheading:3453565-...lld:pubmed
pubmed-article:3453565pubmed:meshHeadingpubmed-meshheading:3453565-...lld:pubmed
pubmed-article:3453565pubmed:meshHeadingpubmed-meshheading:3453565-...lld:pubmed
pubmed-article:3453565pubmed:meshHeadingpubmed-meshheading:3453565-...lld:pubmed
pubmed-article:3453565pubmed:meshHeadingpubmed-meshheading:3453565-...lld:pubmed
pubmed-article:3453565pubmed:meshHeadingpubmed-meshheading:3453565-...lld:pubmed
pubmed-article:3453565pubmed:year1987lld:pubmed
pubmed-article:3453565pubmed:articleTitleEnzymatic synthesis of 3H-labeled Ring-A reduced metabolites of aldosterone and their separation by high pressure liquid chromatography.lld:pubmed
pubmed-article:3453565pubmed:affiliationDepartment of Pathology, Miriam Hospital, Brown University, Providence, RI 02912.lld:pubmed
pubmed-article:3453565pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:3453565pubmed:publicationTypeIn Vitrolld:pubmed
pubmed-article:3453565pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
pubmed-article:3453565pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed